|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0020616,
umls-concept:C0030705,
umls-concept:C0242356,
umls-concept:C0278329,
umls-concept:C0442027,
umls-concept:C0450442,
umls-concept:C0936012,
umls-concept:C1442488,
umls-concept:C1521970,
umls-concept:C1565750,
umls-concept:C1705241,
umls-concept:C1705242,
umls-concept:C2362543
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-6-15
|
|
pubmed:abstractText |
This study examined the relationship of baseline characteristics and medication use in patients with type 2 diabetes who were prescribed sitagliptin versus other oral antihyperglycemic agents in clinical practice settings in the United States.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1697-703
|
|
pubmed:meshHeading |
pubmed-meshheading:20465367-Administration, Oral,
pubmed-meshheading:20465367-Aged,
pubmed-meshheading:20465367-Cohort Studies,
pubmed-meshheading:20465367-Databases, Factual,
pubmed-meshheading:20465367-Diabetes Mellitus, Type 2,
pubmed-meshheading:20465367-Dipeptidyl-Peptidase IV Inhibitors,
pubmed-meshheading:20465367-Electronic Health Records,
pubmed-meshheading:20465367-Humans,
pubmed-meshheading:20465367-Hyperglycemia,
pubmed-meshheading:20465367-Hypoglycemic Agents,
pubmed-meshheading:20465367-Individuality,
pubmed-meshheading:20465367-Middle Aged,
pubmed-meshheading:20465367-Pyrazines,
pubmed-meshheading:20465367-Retrospective Studies,
pubmed-meshheading:20465367-Triazoles,
pubmed-meshheading:20465367-United States
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
|
|
pubmed:affiliation |
Merck Sharp & Dohme Corp., Global Health Outcomes, Whitehouse Station, NJ 08889-0100, USA. qiaoyi_zhang@merck.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
